Get started
Author

Farid Ghamsari

Smartphone-microfluidic fluorescence imaging system for studying islet physiology
2022 · Xiaoyu Yu, Yuan Xing, et al. · Frontiers in Endocrinology · 7
PDF
Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience
2024 · Aaron Trando, Farid Ghamsari, et al. · Biomedicines · 6
PDF
Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience.
2024 · Farid Ghamsari, Aaron Trando, et al. · Journal of Clinical Oncology · 5
PDF
Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginase
2025 · Joseph F. Mort, David Brighton, et al. · Blood Vessels Thrombosis & Hemostasis · 3
P-025 Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience
2024 · Farid Ghamsari, Aaron Trando, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Survival outcomes in patients with primary plasma cell leukemia treated with novel therapies at University of California San Diego Health: A single institution experience.
2024 · Farid Ghamsari, Aaron Trando, et al. · Journal of Clinical Oncology · 1
Outcomes of ide-cel in patients with relapsed/refractory multiple myeloma: A single-institution experience.
2024 · Aaron Trando, Farid Ghamsari, et al. · Journal of Clinical Oncology · 1
PDF
The risks of thrombotic and bleeding events in patients receiving PEGylated asparaginase for treatment of acute lymphoblastic leukemia.
2022 · Ben Mautner, Eric Pierce, et al. · Journal of Clinical Oncology · 1
Microfluidic applications on pancreatic islets and β-cells study for human islet transplant
2021 · Yuan Xing, Pu Zhang, et al. · Elsevier eBooks · 1
Systemic Mastocytosis With Associated Acute Myeloid Leukemia Identified After Induction Therapy: A Case Report and Literature Review
2026 · Joseph Han, Farid Ghamsari, et al. · Cureus
PDF
Comparison of different treatment modalities for favorable risk acute myeloid leukemia: Standard-dose anthracycline versus high-dose anthracycline versus addition of gemtuzumab ozogamicin.
2022 · Joseph Mort, Leah Wells, et al. · Journal of Clinical Oncology
P354: Real-world Analysis of the Risks of Thrombotic and Bleeding Events in Patients Receiving Pegylated Asparaginase for Treatment of Acute Lymphoblastic Leukemia
2022 · B. Mautner, B. Brewer, et al. · HemaSphere
P526: Real-world Comparison of Different Treatment Modalities for Favorable Risk Acute Myeloid Leukemia: Standard Dose Anthracycline Vs High Dose Anthracycline Vs Addition of Gemtuzumab Ozogamicin
2022 · J. Mort, B. Brewer, et al. · HemaSphere
Manifestation of Large Granular Lymphocyte Leukemia in Pediatric and Young Adult Population Is Distinct from Older Adult Cohorts
2021 · Heejin Cheon, Vivian Chan, et al. · Blood
Contributors
2021 · B.G. Abdallah, M.M. Ali, et al. · Elsevier eBooks
An Analysis of the Covarianec of Two Endophenotypic Markers for Depression: Respiratory Sinus Arrhythmia and Frontal EEG Asymmetry
2017 · Farid Ghamsari · UA Campus Repository (The University of Arizona)
Works count: 16
Citation count: 26
H-index: 3
I10-index:
Year
Topic
Type